Iraq vs Mozambique: Treatment success rate for patients treated for MDR-TB
Iraq
76.0%
in 2022
Mozambique
77.0%
in 2022
Iraq rank
64th
Mozambique rank
61st
Treatment success rate for patients treated for MDR-TB over time
- Iraq
- Mozambique
How they compare
Mozambique currently reports 77.0% against 76.0% in Iraq, a difference of 1.0%.
The two have swapped places 7 times across 17 shared years of data; in 2006 it was Iraq ahead.
Iraq ranks 64th and Mozambique ranks 61st of 163 countries.
Across the 3 decades both report, Iraq averaged higher in 2 and Mozambique in 1.
Head to head by decade
| Decade | Iraq | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.2% | 28.5% | 6.8% | Iraq |
| 2010s | 62.4% | 48.7% | 13.7% | Iraq |
| 2020s | 75.0% | 76.3% | 1.3% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Iraq or Mozambique?
- Mozambique, at 77.0% against 76.0% in Iraq as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Iraq and Mozambique?
- 1.0%, with Mozambique ahead.
- How many years of comparable data are there for Iraq and Mozambique?
- 17 years are reported by both, from 2006 to 2022.
- How do Iraq and Mozambique rank globally for treatment success rate for patients treated for mdr-tb?
- Iraq ranks 64th and Mozambique ranks 61st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.